Intra-Cellular Therapies, Inc. Quarterly Common Stock, Shares, Issued from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Intra-Cellular Therapies, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q3 2024.
  • Intra-Cellular Therapies, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 106M shares, a 10.2% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 106M +9.77M +10.2% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 106M +9.54M +9.93% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 97.5M +1.8M +1.88% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 96.4M +1.55M +1.64% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 96.2M +1.52M +1.61% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 96.1M +1.72M +1.82% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 95.7M +1.66M +1.77% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 94.8M +12.9M +15.8% Dec 31, 2022 10-K 2024-02-22
Q3 2022 94.7M +13.3M +16.4% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 94.4M +13.1M +16.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 94M +12.9M +15.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 81.9M +1.42M +1.77% Dec 31, 2021 10-K 2023-03-01
Q3 2021 81.4M +1.23M +1.54% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 81.3M +14.5M +21.8% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 81.1M +14.9M +22.6% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 80.5M +25M +45% Dec 31, 2020 10-K 2022-03-01
Q3 2020 80.1M +24.9M +45.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 66.8M +11.6M +21% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 66.2M +11.1M +20.1% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 55.5M +612K +1.12% Dec 31, 2019 10-K 2021-02-25
Q3 2019 55.2M +534K +0.98% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 55.2M +486K +0.89% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 55.1M +436K +0.8% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 54.9M +298K +0.55% Dec 31, 2018 10-K 2020-03-02
Q3 2018 54.7M +11.3M +26% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 54.7M +11.3M +26% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 54.7M +11.3M +26% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 54.6M +11.3M +26.1% Dec 31, 2017 10-K 2019-02-27
Q3 2017 43.4M +159K +0.37% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 43.4M +174K +0.4% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 43.4M +183K +0.42% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 43.3M +137K +0.32% Dec 31, 2016 10-K 2018-03-01
Q3 2016 43.3M +258K +0.6% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 43.3M +8.21M +23.4% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 43.2M +8.26M +23.6% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 43.2M +13.7M +46.3% Dec 31, 2015 10-K 2017-03-01
Q3 2015 43M +13.6M +46.3% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 35M +5.7M +19.4% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 35M +5.75M +19.7% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 29.5M +7.34M +33.1% Dec 31, 2014 10-K 2016-02-25
Q3 2014 29.4M +7.26M +32.8% Sep 30, 2014 10-Q 2014-11-03
Q2 2014 29.3M +24.3M +487% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 29.2M +24.2M +484% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 22.2M +7.56M +51.8% Dec 31, 2013 10-K 2015-03-12
Q3 2013 22.1M Sep 30, 2013 10-Q 2013-11-05
Q2 2013 5M Jun 30, 2013 10-Q 2013-08-15
Q1 2013 5M Mar 31, 2013 10-Q 2013-08-15
Q4 2012 14.6M Dec 31, 2012 10-K 2014-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.